Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,416.67p
   
  • Change Today:
    -33.33p
  • 52 Week High: 4,050.00p
  • 52 Week Low: 2,300.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 2,871
  • Market Cap: £126.27m

Latest Deals

Traded Action Notifier PriceAmountValue
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
28-Apr-25 Buy Bruce Hiscock 2,632.00p 31 £815.92
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,179,627
Ian James Nicholson 13,000 £314,167
Bruce Hiscock 1,236 £29,870

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £126,141,687
Castlefield Fund Partners Limited 985,000 £23,804,167
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £21,387,500
Gresham House Asset Management Limited 627,782 £15,171,398
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £14,971,250
Miton Group plc 508,135 £12,279,929
The Diverse Income Trust plc 302,300 £7,305,583
Schroders plc 284,795 £6,882,546
Wasatch Advisors, Inc. 265,000 £6,404,167
Raymond James Wealth Management Limited 263,770 £6,374,442
Canaccord Genuity Group Inc 259,940 £6,281,883
Adrian Williams 253,372 £6,123,157

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,416.67p
Change Today -33.33p
% Change -1.36 %
52 Week High 4,050.00p
52 Week Low 2,300.00p
Volume 2,871
Shares Issued 5.22m
Market Cap £126.27m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 10-Sep-2025

Time Volume / Share Price
12:03 169 @ 2,415.00p
11:52 0 @ 2,450.00p
11:52 2 @ 2,450.00p
11:51 102 @ 2,435.00p
11:51 122 @ 2,435.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page